Jocelyn Hudson

75 POSTS 0 COMMENTS

SoniVie receives FDA IDE approval for pilot study to treat hypertension with renal artery denervation TIVUS technology

SonieVie
SoniVie recently announced that on 5 May 2022 the US Food and Drug Administration (FDA) granted inve...

Shockwave Medical and Genesis MedTech obtain regulatory approval in China for intravascular lithotripsy

Shockwave Medical and Genesis MedTech Group announced today that they have successfully obtained app...

Vivasure Medical announces Series D financing to advance portfolio of PerQseal vessel closure devices

Vivasure Medical has announced the closing of the first tranche of €22 million (US$23 million) as pa...

Artificial intelligence could make endovascular aortic repair outcomes more predictable

At the 2022 Charing Cross (CX) International Symposium (26–28 April, London, UK), Tom Carrell (C...

CX returns to in-person format once more in the London spring

Charing Cross (CX) chair Roger Greenhalgh welcomes the vascular community to this year's symposium, ...

Death due to cardiovascular disease more likely among Black adults born in the USA

Black adults born in the USA had a higher rate of death from cardiovascular diseases and all cau...

Study suggests a more proximal landing zone is preferred for TEVAR of acute type B aortic dissections

A review evaluating the results of thoracic endovascular aortic repair (TEVAR) following acute t...

New publication “extends evidence for clinical benefit” with CytoSorbents’ haemoadsorption technology into type A dissection aortic surgery

CytoSorbents has called attention to a new publication which reports on the use of intraoperative ha...

Prolonged TV watching may increase risk of venous thromboembolism

A new study reports that watching TV for four hours a day or more is associated with a 35% higher ri...

Philips integrates cloud-based AI and 3D mapping into its mobile C-arm system series

Royal Philips today announced physicians will now have access to advanced new 3D image guidance ...

Cardiovascular Systems announces development of IVL technology for the treatment of coronary and peripheral arterial diseases

IVL
Cardiovascular Systems recently announced that it has made significant progress towards the commerci...

Vesalio initiates clinical study evaluating enVast thrombectomy system in patients with STEMI

Vesalio
Vesalio recently announced the start of enrolment in its NATURE study using enVast, the company’s fi...

Machine learning may help identify people at risk of thoracic aortic aneurysm

A team led by investigators at Massachusetts General Hospital (MGH) in Boston, USA, recently used de...

Research reveals improved outcomes and decreased mortality in management of aortic dissections with care plans designed by multidisciplinary expertise

The Minneapolis Heart Institute Foundation (MHIF; Minneapolis, USA) has announced the publication of...

Type A dissection enters a new revolution

“We are at the beginning of a type A dissection revolution,” Joseph E Bavaria (University of Pen...

New technologies will simplify and shorten aortic surgical procedures while reducing radiation

In a session on “Reduction of radiation challenges” at CX Aortic Vienna 2021 (5–7 October, broad...

Patients should get a choice between open and endovascular surgery for aortic conditions, CX audience agrees

A decisive vote at CX Aortic Vienna 2021 (5–7 October, broadcast) revealed that 90% of the audie...

Open surgery remains a well-accepted as option to treat challenging aortic arch

Results of a poll conducted at CX Aortic Vienna 2021 (5–7 October, broadcast) indicated that ope...

First patient treated with Cardiovascular Systems’ ViperCross peripheral support catheter

Cardiovascular Systems
Cardiovascular Systems recently announced that the first patient has been successfully treated with ...

MedAlliance announces first patient enrolment in SELUTION DeNovo study

MedAlliance today announced first patient enrolment in the coronary randomised controlled study SELU...

EuroPCR 2021: Late-breaking data demonstrate long-term benefits of Medtronic radiofrequency renal denervation in real-world hypertensive patients

Medtronic today announced new clinical data from the Global SYMPLICITY registry (GSR) indicating...

Results from EXTRACT-PE trial of Penumbra’s Indigo aspiration system published

Results from the EXTRACT-PE trial, which found that Penumbra’s Indigo aspiration system met its ...

Inaugural CX Aortic Vienna to take place online

CX Aortic Vienna
The inaugural CX Aortic Vienna meeting will be livestreamed 8–11 September 2020 to an international,...

Philips and the US government collaborate in ventilator production ramp up to combat COVID-19 pandemic

Royal Philips has announced that the US government and Philips agreed to team up to increase the pro...

ACS defends healthcare workers as PPE shortages lead to acrimony

The American College of Surgeons (ACS) today leapt to the defense of healthcare workers who are ...

Virtual ACC: Clopidogrel exposure along with aspirin and rivaroxaban should be “minimised or avoided” in PAD revascularisation

“More bleeding with background clopidogrel, even if not severe by adjudication, may be associate...

Virtual ACC: Antiplatelet drugs increase risk for TAVI patients with atrial fibrillation

In the POPULAR TAVI trial, patients with atrial fibrillation who took oral anticoagulants alone ...

New guideline: ASA no longer recommended to prevent first stroke, heart disease

A new Heart & Stroke guideline published today in the Canadian Medical Association Journal does ...

ACURATE neo helps facilitate early discharge following TAVI procedures

NOTE: This video is ONLY available to watch in selected countries and geographies Rajesh ...

Ablative Solutions publishes data from the Peregrine post-market study

Ablative Solutions has revealed that positive six-month results from the Peregrine post-market s...

Medtronic begins pilot study as part of SPYRAL HTN clinical programme for renal denervation in hypertension patients

Medtronic has announced that it will begin enrolment in a pilot study evaluating the safety and effi...

IVL has “changed the dynamics” of facilitating EVAR & TEVAR in calcified iliac arteries

Frank Arko at Veith TV
 Frank Arko (Charlotte, USA) talks to VEITHtv at the VEITHsymposium 2019 (19–23 November, New Yo...

Shockwave IVL can aid in eliminating recoil and dissection during below-the-knee angioplasty

George Adams (Raleigh, USA) talks to VEITHtv at the VEITHsymposium 2019 (19–23 November, New Yor...

ECHSA 2019: Shape matters and is an innovation

Martin Kostelka (Leipzig, Germany), who was the first to use the CardioCel 3D (Admedus) product ...

CardioCel benefits patients with different anatomies for intracardiac application

Speaking to Cardiovascular News at the ECHSA 2019 meeting (European Congenital Heart Surgeons As...

CardioCel 500—Long term experience with no calcification

Giovanni Stellin (Padova, Italy) talks to Cardiovascular News at the ECHSA 2019 meeting (Europea...

Renal denervation still holds strong potential as a therapy for hypertension

Although renal denervation may not hit the heights originally envisaged for it in the management of ...

Low-dose polypill could be used for primary prevention of cardiovascular events

A polypill that combines four cardiovascular drugs has been shown to reduce the risk of major cardio...

FARXIGA meets primary endpoint in Phase III DAPA-HF trial

AstraZeneca has announced positive results from the Phase III DAPA-HF trial which showed that FA...

CeloNova appoints new president and CEO

CeloNova has announced the appointment of Carl J St. Bernard as president and chief executive office...

FDA approves new device to improve symptoms in patients with advanced heart failure

The US Food and Drug Administration has approved the Barostim Neo system for the improvement of ...

Novel wireless pressure monitoring system will have an “enormous impact” on HF patient care

Horst Sievert (Frankfurt, Germany) talks to BLearning at EuroPCR 2019 (21–24 May, Paris, France)...

Announcing the TCT 2019 late-breaking trials and science

The Cardiovascular Research Foundation (CRF) has announced the 12 late-breaking trials and 16 late-b...

Cardiovascular Systems acquires Gardia Medical’s Wirion embolic protection system

wirion
Cardiovascular Systems recently announced that it has acquired the Wirion embolic protection sys...

Transcatheter repair of tricuspid valves appears safe and effective when surgery is not an option

Data from two new studies suggest that transcatheter tricuspid valve repair (TTVr) is a safe and...

Hormone therapy linked to heart fat and hard arteries

Hormone replacement therapy is a common treatment for menopause-related symptoms, and new research f...

SeQuent Please ReX drug-coated PTCA balloon catheter receives FDA breakthrough device designation

B Braun Interventional Systems has announced that the US Food and Drug Administration (FDA) has gran...

EuroPCR 2019: Allegra Transcatheter Heart Valve shows “very good haemodynamic outcomes”

Ulrich Schäfer (Hamburg, Germany) speaks to Cardiovascular News at EuroPCR (21–24 May, Paris) ab...

TRILUMINATE trial shows “extremely favourable” results in patients with tricuspid regurgitation

Speaking to Cardiovascular News at EuroPCR 2019 (21–24 May, Paris, France), Georg Nickenig (Bonn...

ADVERTORIAL: Edwards PASCAL™ Transcatheter Valve Repair System is innovative

pascal repair
This content is only for readers outside of the US as it discusses a device that is not FDA appr...

Philips launches IntraSight interventional applications platform

Royal Philips recently announced the launch of the new IntraSight interventional applications pl...

Boston Scientific initiates trial comparing left atrial appendage closure to direct oral anticoagulants for stroke risk reduction post-AFib ablation

According to a press release, Boston Scientific has initiated the OPTION trial to compare safety...

Medtronic launches Telescope guide extension catheter

Medtronic recently announced the global launch of the Telescope guide extension catheter, a newl...

CE mark for Watchman FLX left atrial appendage closure device

Boston Scientific announced it has received CE mark and initiated a limited market release of the ne...

Vascular Dynamics names Martin Rothman chief medical officer

Martin T Rothman has been appointed as chief medical officer of Vascular Dynamics, effective 1 Janua...

Vascular Dynamics names Martin Rothman chief medical officer

Martin T Rothman has been appointed as chief medical officer of Vascular Dynamics, effective 1 Janua...

Philips launces Azurion with FlexArm to aid image-guided procedures

Philips launches its Azurion with FlexArm to aid patient imaging and positioning during image-gu...

Positive results for LivaNova’s Perceval sutureless valve

Three newly published studies highlight the safety, efficacy, and economic advantage of the Perv...

Abbott to acquire Cephea Valve Technologies

It was recently announced that Abbott has exercised its option to purchase Cephea Valve Technologies...

New JACC publication reinforces valve of a coronary CTA + HeartFlow Analysis-guided pathway for diagnosing heart disease

HeartFlow has announced the publication of the PACIFIC substudy showing that their FFRct Analysi...

JenaValve Technology appoints John T Kilcoyne as chief executive officer

Medical device executive John T Kilcoyne has been appointed as chief executive officer of JenaValve ...

Shockwave initiates US pivotal study for coronary intravascular lithotripsy

  Shockwave Medical has initiated its US Food and Drug Administration (FDA) Investigatio...

First patients in the Middle East treated with Diamondback 360 Coronary Orbital Atherectomy System

  The first patients in the United Arab Emirates (UAE) have been treated with the Diamon...

Sleeping less than six hours a night may increase cardiovascular risk

People who sleep less than six hours a night may be at increased risk of cardiovascular disease comp...

FDA approves world’s first device for treatment of premature babies and newborns with an opening in their hearts

The US Food and Drug Administration (FDA) has approved the Amplatzer Piccolo Occluder (Abbott), ...

Boston Scientific, Edwards Lifesciences agree to global litigation settlement

Boston Scientific and Edwards Lifesciences today announced that the companies have reached an agreem...

Does your insurance card matter when you have a heart attack?

Medicaid reimbursement to healthcare facilities on ST-elevation myocardial management—or STEMI, a se...

SCCT releases new guideline for use of computed tomography in TAVR procedure

The Society of Cardiovascular Computed Tomography (SCCT) has released a new expert consensus doc...

Patient recruitment reaches half-way point for global DAPT study

December marked a significant milestone for a major study into the use of short duration dual an...

First United States treatment with J-Valve TAVI device

The first US patient has been successfully treated with JC Medical's transfemoral transcatheter ...

Sapien 3 Ultra receives FDA approval

Sapien 3
It has been announced that the Sapien 3 Ultra system (Edwards Lifesciences) has received US FDA ...

Internationally renowned cardiac surgeon joins University of Miami Health System

Joseph Lamelas, an internationally recognised expert cardiac surgeon who helped pioneer minimall...

FFRangio system receives US FDA clearance

US FDA 510(k) clearance has been granted for the FFRangio System (CathWorks). The FFRangio syste...

Boston Scientific exercises option to acquire Millipede

Boston Scientific has exercised its option to acquire the remaining shares of Millipede, upon it...

First patients treated in United States with OrbusNeich Teleport Microcatheter

The first patients in the United States have been treated using the OrbusNeich Teleport Microcathete...